RPTX - Repare Therapeutics GAAP EPS of -$0.91 misses by $0.06 revenue of $0.67M August, 04 2022 05:27 PM Repare Therapeutics Inc. Repare Therapeutics press release ( NASDAQ: RPTX ): Q2 GAAP EPS of -$0.91 misses by $0.06 . Revenue of $0.67M (+139.3% Y/Y). For further details see: Repare Therapeutics GAAP EPS of -$0.91 misses by $0.06, revenue of $0.67M